What is Breakthrough T1D's contact information?

Breakthrough T1D's contact information: +18005332873.

How many employees does Breakthrough T1D have?

Breakthrough T1D has 800 employees.

What are Breakthrough T1D's official social media profiles?

Breakthrough T1D Linkedin Page Breakthrough T1D Facebook Page Breakthrough T1D Instagram Page Breakthrough T1D Twitter Page

What tech stack does Breakthrough T1D use?

Some of the popular technologies that Breakthrough T1D uses are: Optimizely, UserWay, StackAdapt.

What are Breakthrough T1D's office addresses?

Breakthrough T1D has a known office at the following address: 200 Vesey Street 28th Floor New York , New York 10281, US.

What is Breakthrough T1D's open headcount?

Breakthrough T1D has 3 job postings.

What is the number of ad campaigns for Breakthrough T1D?

Breakthrough T1D has no advertisements yet.

What is the number of recent news articles about Breakthrough T1D?

Breakthrough T1D has 5 news articles.

Breakthrough T1D - Pubrio Company Profile & Intent

Q: What industry does Breakthrough T1D belong to?

Breakthrough T1D is in the industry of: Nonprofit Organization Management, Research, Healthcare, Non-profit, Non-profit Organizations.

Breakthrough T1D

United States · Non-profit Organizations

Nonprofit Organization Management

Research

Healthcare

Non-profit

Non-profit Organizations

JDRF is now Breakthrough T1D. As the leading global type 1 diabetes research and advocacy organization, Breakthrough T1D helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition. For more information, visit www.BreakthroughT1D.org

Company Insights

prnasia.com · partners_with · one week ago

Open news

Continuity Biosciences partners with Breakthrough T1D for diabetes therapy

Continuity Biosciences and Breakthrough T1D partner to advance NICHE platform for type 1 diabetes cell therapy, aiming for first-in-human clinical trial.

prnasia.com · partners_with · one week ago

Open news

Continuity Biosciences and Breakthrough T1D partner for diabetes therapy

Continuity Biosciences and Breakthrough T1D partner to advance NICHE cell therapy platform for type 1 diabetes to first-in-human clinical trials, combining expertise in drug delivery and diabetes innovation.

prnasia.com · partners_with · one week ago

Open news

Continuity Biosciences and Breakthrough T1D collaborate on T1D therapy

Continuity Biosciences and Breakthrough T1D announce strategic collaboration to develop NICHE® cell therapy platform for type 1 diabetes, supporting IND filing and phase 1/2a clinical trial planning.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin option investors bet on downside despite price rise

Bitcoin ETF and crypto-holding firms are buying put options to hedge against potential price drops below $60,000, despite recent price increases.

khgames.co.kr · is_developing · 2026-03-03

Open news

Bitcoin's 'Death Cross' Appears: Future Trends?

Bitcoin chart shows 'death cross' pattern, historically preceding major price drops. Despite this, ETFs see $1 billion inflow and long-term investors continue accumulating.

coinreaders.com · launches · 2026-03-02

Open news

JPMorgan: Crypto Market Structure Act likely to pass mid-year

JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.

Get full access to view complete information

1 - 5 of 5

Frequently Asked Questions Regarding Breakthrough T1D

Company Overview

1970

Founded

Non-profit Organizations

Industry

United States

Location

133,121

Ranking

800 employees

Size

Similar Companies

Get full access to view complete information